https://www.pharmexec.com/view/helping-small-biotechs-startups-navigate-complexities-accelerate-time-market
Oct 8, 2025 - With ever-increasing costs to put a single molecule on the market, the pressure to reach clinical milestones quickly and efficiently often drives a focus on...
helpingsmallbiotechsstartupsnavigate
https://www.forbes.com.au/covers/innovation/the-australian-biotechs-racing-toward-the-next-billion-dollar-cancer-drug/
Nov 16, 2025 - Three Australian biotechs are in the billion-dollar race to find new ways of attacking cancer with CAR-T therapies.
aussiecarracebiotechschasing
https://endpoints.news/in-the-scramble-for-capital-biotechs-turn-to-royalty-deals/
Aug 15, 2025 - Royalty deals surge as biotech funding tool, with Aquestive-RTW deal latest example. KKR, OrbiMed, XOMA active in space. MacroGenics, Syndax among companies...
scramblecapitalbiotechsturnroyalty
https://www.allucent.com/resources/blog/empowering-small-biotechs-conquering-clinical-trial-challenges-with-data-management-champions
Jul 21, 2025 - Explore how small biotechs can conquer clinical trial challenges with effective data management strategies and champions. Learn their role in driving success...
clinical trialdata managementempoweringsmallbiotechs
https://clarivate.com/life-sciences-healthcare/blog/six-companies-enabling-precision-interventions-for-undruggable-targets/
Nov 25, 2025 - Discover six biotech firms pioneering protein degraders to treat undruggable diseases like cancer, autoimmune, and neurodegenerative conditions.
biotechstargetingprecision
https://endpoints.news/struggling-biotechs-succumb-to-icy-market-as-money-dries-up-and-clinical-bets-dont-pay-off/
Jun 4, 2025 - The steady drumbeat of restructurings, pipeline cuts, layoffs and short-lived pivots have made 2025 feel nothing like the comeback year sought by many in...
strugglingbiotechssuccumbicymarket
https://endpoints.news/chinese-biotechs-work-on-cheaper-alternatives-to-2m-zolgensma/
Oct 9, 2025 - Indian veterinarian Nirnay Murthy sought Lantu Biopharma's experimental gene therapy for his son's spinal muscular atrophy after being unable to afford...
chinesebiotechsworkcheaperalternatives
https://www.bioworld.com/articles/726207-us-european-biotechs-lead-budding-organ-on-a-chip-market?v=preview
U.S. and European organ-on-a-chip specialty biotechnology companies are driving development of organ-on-a-chip technologies, fueled by the U.S. FDA’s...
useuropeanbiotechsleadbudding
https://www.statnews.com/2024/05/23/weight-loss-drugs-rna-interference-gene-silencing-regeneron/
May 24, 2024 - As shown in STAT’s Obesity Drug Tracker, Regeneron and others are using RNA interference to target genetics, rather than hormones like GLP-1.
longer lastingobesitydrugsbiotechsturn
https://www.swissinfo.ch/eng/global-trade/chinese-biotechs-eye-swiss-collaboration-as-relations-with-us-sour/89285587
May 15, 2025 - With growing uncertainty in the US, Chinese companies are swooping in to present themselves as stable, open partners to the Swiss biotech sector.
chinesebiotechseyeswisscollaboration
https://clarivate.com/life-sciences-healthcare/blog/forecasting-target-markets-using-epidemiology-data/
Jan 8, 2026 - A look at the Clarivate methodology for using epidemiology data to size market potential, profile patient segments and make confident business decisions based...
usingepidemiologydataforecastmarkets
https://www.prweek.com/article/1940362/dna-communications-trots-dnahelix-global-strategic-comms-support-biotechs
DNA Communications trots out dnaHelix, global strategic comms support for biotechs. From PR Week
dnacommunicationstrotsglobalstrategic